SYBX: Synlogic, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.96
Enterprise Value ($M) -2.43
Book Value ($M) 13.11
Book Value / Share 1.12
Price / Book 1.29
NCAV ($M) 13.06
NCAV / Share 1.12
Price / NCAV 1.30

Profitability (mra)
Return on Invested Capital (ROIC) -2.84
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.87

Liquidity (mrq)
Quick Ratio 2.71
Current Ratio 2.71

Balance Sheet (mrq) ($M)
Current Assets 20.70
Assets 20.75
Liabilities 7.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -52.22
05-16 13D/A New Enterprise Associates 14, L.P. 25.00 0.00
04-18 13G Radoff Bradley Louis 5.40
02-16 13D Funicular Funds, LP 36.00
02-14 13G/A Kryzanowski John A 9.51 -80.32
02-09 13G/A Fmr Llc 2.81 -60.01

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-13 1,596 15,831 10.08
2025-01-10 8,987 73,610 12.21
2025-01-08 13,141 28,207 46.59

(click for more detail)

Similar Companies
SRZN – Surrozen, Inc. SXTC – China SXT Pharmaceuticals, Inc.
SXTP – 60 Degrees Pharmaceuticals, Inc. TCRT – Alaunos Therapeutics, Inc.
TELO – Telomir Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io